Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


Archive of News

<< 2012 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2014 >>

22 February 2013: UCL Business licenses gene therapy programme for haemophilia to BioMarin Pharmaceuticals

UCLB today announced that it has licensed a Factor VIII gene therapy program for haemophilia A to BioMarin Pharmaceuticals Inc (BMRN) using the research from Professor Amit Nathwani and his team at UCL and  St. Jude Children’s Research Hospital. More...

20 February 2013: International Centre for Entrepreneurship Policy launched

A new database documenting public and private sector initiatives to encourage entrepreneurship has been launched by UCL Advances. More...

11 February 2013: Helping hand of SMILE programme prepares Fulham Clinic for next stage of expansion

As mentoring requests go, it wasn’t the usual type of request which Ruth Hou, business support manager at UCL Advances, deals with in her role of overseeing mentoring for small business in London – a trichologist, or hair and scalp care specialist, looking to expand her London clinic. More...

4 February 2013: UCL CONSULTANTS LTD APPOINTS NEW MANAGING DIRECTOR

Roger de Montfort joins as new head from Global Professional Services firm PricewaterhouseCoopers.
More...

<< 2012 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2014 >>